What is the next earnings date for ALBIO stock?
BIOSYNEX (ALBIO.PA) will report earnings on 2026-04-22.
BIOSYNEX (ALBIO.PA) Forecast, Price Target & Analyst Ratings
EPA:ALBIO • FR0011005933
Current stock price
0.85 EUR
0 (0%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOSYNEX (ALBIO.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of €0.85 to mean target of N/A, Based on 9 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
86.67%
ALBIO.PA was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ALBIO.PA.
In the previous month the buy percentage consensus was at a similar level.
ALBIO.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 22, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 196.6M -48.60% | 92.978M -52.71% | 101.167M 8.81% | 146.47M 44.78% | |
| EBITDA YoY % growth | 65.7M -53.93% | -23.945M -136.45% | -15.799M 34.02% | 14.317M 190.62% | |
| EBIT YoY % growth | 38.8M -72.40% | -37.404M -196.40% | -36.333M 2.86% | 5.974M 116.44% | |
| Operating Margin | 19.74% | -40.23% | -35.91% | 4.08% | |
| EPS YoY % growth | N/A | N/A | N/A 103.92% | 0.47 475.00% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BIOSYNEX / ALBIO.PA Forecast FAQ
How do analysts rate BIOSYNEX (ALBIO.PA)?
The consensus rating for BIOSYNEX (ALBIO.PA) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.